The investigators found increased expression of TGFβ-activated kinase 1 (TAK1) and downstream signaling molecules, including TNFα, IL-6 and IL-1β, in monocytes from patients with GvHD compared to patients who did not experience GvHD after allo-HCT. This evidence concerns the gene IL1B and graft versus host disease.